Avid Bioservices Inc (CDMO)

[goodJohnhunting]

John, thanks for responding. It seems I am mostly "getting it" regarding the PPHM tech, but you are identifying unrefined pathways where the anti PS benefits linked with those of other substances places Bavi family treatment back into the anti viral realm. Complicated and fascinating.

To be more specific, the mevalonate pathway.

It's when this pathway is inhibited that a potential benefit, ie cancer or viral synergy exist. There is also ongoing study in regards to apoptosis and the mevalonate cascade.

These are identified, and I'm just suggesting a potential synergy between inhibiting PS pathway and mevalonate pathway.

I also believe there would be effects in cell structure, fatty acid distribution and binding protein availability. Thus, a potential benefit in regards to antiPS and immunomodulation.

Regarding OHPSLSAE, this is simply an unidentified exosome or biomarker.

All the best,
John